Steven R. Sarkisian
NEW YORK — Patients with glaucoma who were treated with either a fast-elution or slow-elution rate travoprost intraocular implant experienced a 30% reduction in IOP out to 1 year, according to a poster presentation here.
“Even at 1 year with this implant in the eye releasing travoprost, the average pressure reduction was 32%. The point of this was not to demonstrate superiority of travoprost over timolol, but to show the safety of this implant in the eye, which we very well demonstrated. Of interest, there was no (Read more...)
Uncategorized